Lecture 6: Study Design I: Clinical Trials Reading Gordis - Chapters 6, 7 Lilienfeld and Stolley - Chapters 8, 9.

Slides:



Advertisements
Similar presentations
Randomized controlled trials
Advertisements

Andrea M. Landis, PhD, RN UW LEAH
Randomized Controlled Trial
Department of O UTCOMES R ESEARCH. Daniel I. Sessler, M.D. Professor and Chair Department of O UTCOMES R ESEARCH The Cleveland Clinic Clinical Research.
Experimental Studies. Types of Experimental Studies Multiple experimental groups Blinds single, double, triple.
Research Study Designs
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
KINE 4565: The epidemiology of injury prevention Randomized controlled trials.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Basic Design Consideration. Previous Lecture Definition of a clinical trial The drug development process How different aspects of the effects of a drug.
天 津 医 科 大 学天 津 医 科 大 学 Clinical trail. 天 津 医 科 大 学天 津 医 科 大 学 1.Historical Background 1537: Treatment of battle wounds: 1741: Treatment of Scurvy 1948:
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Biostatistics - Concepts Tudor Calinici – JPEMS 2014.
Chapter 5 Producing Data
Design and Analysis of Clinical Study 12. Randomized Clinical Trials Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
Clinical Trials Medical Interventions
Sampling and Experimental Control Goals of clinical research is to make generalizations beyond the individual studied to others with similar conditions.
25/5/2009 Dr. Salwa Tayel 1. 25/5/2009 Dr. Salwa Tayel2 Associate Professor Family and Community Medicine Department King Saud University By.
Clinical trial The Way We Make Progress Against Disease Prof. Ashry Gad Mohamed Prof. of Epidemiology College of Medicine & KKUH.
Clinical Trials Hanyan Yang
EVIDENCE BASED MEDICINE
Experimental Study.
CLINICAL TRIALS AUTHOR Dr.A. K. AVASARALA MBBS,M.D. PROFESSOR &HEAD DEPT OF COMMUNITY MEDICINE & EPIDEMIOLOGY PRATHIMA INSTITUTE OF MEDICAL SCIENCES, KARIMNAGAR,A.P..
Accredited Member of the Association of Clinical Research Professionals, USA Tips on clinical trials Maha Al-Farhan B.Sc, M.Phil., M.B.A., D.I.C.
BC Jung A Brief Introduction to Epidemiology - XI (Epidemiologic Research Designs: Experimental/Interventional Studies) Betty C. Jung, RN, MPH, CHES.
Research Design Interactive Presentation Interactive Presentation
Multiple Choice Questions for discussion
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Randomized Controlled Trials 随机临床试验
 Be familiar with the types of research study designs  Be aware of the advantages, disadvantages, and uses of the various research design types  Recognize.
Intervention Studies Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE.
Experimental Study Design RCT. EXPERIMENTAL Exposure manipulated by Investigator DescriptiveAnalytic Exposure NOT manipulated by Investigator OBSERVATIONAL.
Lecture 16 (Oct 28, 2004)1 Lecture 16: Introduction to the randomized trial Introduction to intervention studies The research question: Efficacy vs effectiveness.
What is a Clinical Trial (alpha version) John M. Harris Jr., MD President Medical Directions, Inc.
Study Design. Study Designs Descriptive Studies Record events, observations or activities,documentaries No comparison group or intervention Describe.
1 Experimental Study Designs Dr. Birgit Greiner Dep. of Epidemiology and Public Health.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Applied Epidemiology Sharla Smith. Discussion Assignments How to complete a discussion assignment –Read the chapters –Evaluate the question –Be very specific.
Experimental Studies Dr Amna Rehana Siddiqui Dr Abdul Aziz Bin Saeed.
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
Chapter 2 Research in Abnormal Psychology. Slide 2 Research in Abnormal Psychology  Clinical researchers face certain challenges that make their investigations.
CHP400: Community Health Program - lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Present: Disease Past: Exposure Cross - section.
Lecture 5 Objective 14. Describe the elements of design of experimental studies: clinical trials and community intervention trials. Discuss the advantages.
EXPERIMENTAL EPIDEMIOLOGY
بسم الله الرحمن الرحيم جامعة أم درمان الإسلامية كلية الطب و العلوم الصحية - قسم طب المجتمع مساق البحث العلمي / الدفعة 21 Basics of Clinical Trials.
Copyright © 2016 Wolters Kluwer All Rights Reserved Chapter 7 Experimental Design I— Independent Variables.
Compliance Original Study Design Randomised Surgical care Medical care.
Handbook for Health Care Research, Second Edition Chapter 7 © 2010 Jones and Bartlett Publishers, LLC CHAPTER 7 Designing the Experiment.
Penn CTSI Research Seminar Clinical Trials November 10, 2015 Vernon M. Chinchilli, PhD Distinguished Professor and Chair Department of Public Health Sciences.
Design of Clinical Research Studies ASAP Session by: Robert McCarter, ScD Dir. Biostatistics and Informatics, CNMC
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
Purpose of Clinical Trials Assess safety and efficacy of Experimental treatments New combinations of drugs New approaches to surgery or radiation therapies.
. Clinical Trials Copyright © Texas Education Agency, All rights reserved.
Uses of Diagnostic Tests Screen (mammography for breast cancer) Diagnose (electrocardiogram for acute myocardial infarction) Grade (stage of cancer) Monitor.
Purpose of Epi Studies Discover factors associated with diseases, physical conditions and behaviors Identify the causal factors Show the efficacy of intervening.
Journal Club Curriculum-Study designs. Objectives  Distinguish between the main types of research designs  Randomized control trials  Cohort studies.
Welcome Clinical Trials October 11, 2016 Vernon M. Chinchilli, PhD
Overview of the Scientific Method
CLINICAL PROTOCOL DEVELOPMENT
Clinical Trials Medical Interventions
Randomized Trials: A Brief Overview
Design of Clinical Trials
Conducting Experimental and Quasi-Experimental Research
EXPERIMENTAL STUDIES.
Clinical Trials.
Strength of Evidence; Empirically Supported Treatments
EXPERIMENTAL STUDIES.
Experimental Studies.
HEC508 Applied Epidemiology
Presentation transcript:

Lecture 6: Study Design I: Clinical Trials Reading Gordis - Chapters 6, 7 Lilienfeld and Stolley - Chapters 8, 9

Types of studies Experimental: randomized clinical trials Non-experimental (observational): –Prospective (cohort) studies –Retrospective (case-control) studies

Objectives of randomized trials Evaluate therapeutic and preventive aspects of medical practice Evaluate new approaches to health care delivery Evaluate impact of health education on health behavior

Design of a randomized trial Study Population RANDOMIZATION New TreatmentCurrent Treatment Not Improved Improved Not Improved Reference population

Randomized control trials (RCT) RCT are generally regarded as the most scientifically rigorous method of hypothesis testing available in epidemiology. RCT have greatest control over the research setting –manipulation of study factor –random assignment of exposure

Study Population RANDOMIZATION New TreatmentCurrent Treatment Not Improved Improved Not Improved Reference population

Considerations in selecting a study population Source (reference) population: the population for whom the results of the intervention are thought to be applicable. Target (study) population: the group in which the intervention is conducted Our objective is to generalize the results beyond the study population

Considerations in selecting a study population Internal validity is the ability to reach the correct conclusion in those actually studied –Absence of methodologic problems in the study External validity is the generalizability of the study to the reference population –Do studies of physicians REALLY represent the general population?

New TreatmentCurrent Treatment Random Allocation Source population Eligible Consent to participate Ineligible Decline participation Study population

Subject selection: factors to consider in setting eligibility criteria 1.Potential benefits and risks of intervention(s) a.Who would be expected to reap benefits from the new intervention? b.For whom would the new intervention pose unacceptable risks? (Example: known allergy).

2.Need to think proactively about internal validity of trial a.Ability of subjects to provide valid and reliable data: e.g., intact mental status, language fluency b.Expected compliance with a regimen. c.Low probability of dropping out: e.g., expectation of continued residence in community, absence of serious comorbidity.

3.Enhancement of the power of the trial a.May restrict participation to a group with known high incidence of relevant outcome(s). b.May restrict to a relatively homogeneous study population, in order to reduce variability in outcome. c.May use matching to reduce variability in outcomes from sources other than exposure.

“Controlled trial of sotalol for one year after myocardial infarction” Julian et al.(1982) Lancet 1: A multicenter (25) double-blind randomized study. Treatment: 320 mg sotalol once daily compared to placebo in patients surviving acute myocardial infarction (MI) Patients between the ages of 30 and 69 years who had survived for five days after MI were evaluated for inclusion Treatment started 5-14 days after infarction

Subjects were excluded (55% of those eligible for the study) for the following reasons: –heart block of >1st degree –heart rate < 54 per minute –women of child bearing years –history of asthma or obstructive airway disease –IDDM –clinical evidence of infarction at 12th post- infarction day Julian et al.(1982) Lancet 1:

MORE exclusions! –Systolic BP persistently < 100 mm Hg –other cardiac or non-cardiac conditions thought to be serious enough to worsen short term diagnosis –lack of cooperation by patient or inability to follow up the patient for psychological or geographical reasons (!) Julian et al.(1982) Lancet 1:

New TreatmentCurrent Treatment Random Allocation Source population Eligible Consent to participate Ineligible Decline participation Study population

Informed Consent By federal regulations this means subjects must be told: 1.That they would be participating in research 2.The research procedures involved. 3.The potential risks and discomfort 4.The potential benefits (including those to society) 5.Alternative procedures of possible advantage to subjects

Informed Consent And that’s not all…. 6.Extent to which information gathered will remain confidential 7.Medical services available in the event of an injury, if more than minimal risk involved. 8.Whom to contact with questions about research. 9.Voluntary nature of participation and right to withdraw without penalty or loss of benefits

New TreatmentCurrent Treatment Random Allocation Source population Eligible Consent to participate Ineligible Decline participation Study population

Randomization Randomization: –Equal probability of participants to be assigned to intervention or control group –This is the basis for statistical inference By randomly assigning the treatment - reduce the risk of confounding because: “confounders - known and unknown” are randomly distributed among the treatment groups By blinding (masking) assessment of outcome - reduce the risk of information bias

Methods of randomization: simple random allocation Subjects assigned on entry to a treatment group based on some pre-determined allocation plan –table of random numbers – flipping a coin If the study is small, this method MAY result in differences in group size or composition by chance

Methods of randomization: stratified randomization Randomization increases the likelihood of comparability, but does not guarantee it Stratify by variables that are known to be important (such as age) and randomize within each strata Guarantees groups are comparable with regard to the important variable

Example: stratified randomization 1,000 Patients 600 males 400 females 360 young 240 old 300 young 100 old = = 500 New treatment Current treatment Stratify by sex Stratify by age

How would an investigator know if the randomization procedure was successful? Check baseline characteristics between the two groups. For example, Sotalol groupPlacebo group 54% male53% male 95% Caucasian96% Caucasian mean age = 54.5mean age = 55.2

Blinding Blinding is when the observers and/or subjects are kept ignorant as to the group to which the subjects are assigned Single blind = subjects are ignorant Double blind = observer and subject are ignorant Triple blind = observer, subject and analyst are ignorant

Why use blinding? Use blinding to eliminate the effect of knowledge of treatment- this introduces bias –If a patient is aware of assignment, knowledge of therapy may affect outcome (use a placebo) –Observer may differentially recognize and record information regarding the patient based on the treatment group of the subject

What are typical comparison or control groups in RCTs? 1.Placebo a.A biologically inert intervention which is used to elicit any non-specific psychological effects of the test intervention. b.Designed to resemble the test intervention as closely as possible, except for the presumably active component.

2.Using a specific alternative intervention a.For example, comparing Vaccine A versus Vaccine B. b.Sometimes used to test a hypothesis of equal efficacy (or bioequivalence), possibly comparing a new intervention to the best existing alternative.

3.“Usual care” comparison group a.Used chiefly in trials that are investigating methods of health care delivery or health education. b.Requires careful attention to what is actually provided to the control group, so that findings are interpretable.

Sample size in clinical trials How many people do we have to study to obtain a statistically significant difference between the groups? Sample size is calculated before the study starts. Calculate the number that guarantees the power (1-  ) of the study. –See Gordis pp for details

Planned crossover Group 1 Group 2 Group 1

Planned crossover Each patient can serve as his/her own control, thus holding constant the variation between individuals. Cautions: –Carryover effects: need a washout period to eliminate the effect from one treatment to another. –Order of treatments: may because of psychological responses –Not feasible for some treatments, e.g., surgery

Unplanned crossover Randomized Surgical care Medical care Randomized Refused surgery Require surgery Surgery No surgery Surgical care Medical care Original designReality

Unplanned crossover Analyze the unplanned crossover: intention to treat- according to the original randomized assignment.

Noncompliance (dropout) Patients may agree to be randomized, but they may not comply with the assignment treatment. The effect of noncompliance will be to reduce observed differences- non-ignorable missingness. How to know the non-ignorable missingness? –Record the demographic characteristics of noncompliance –Compare compliers and noncompliers in these characteristics

Phases in new drug testing in US Phase I: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. Phase II: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety. Phase III: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. Phase IV: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.